Back to results
US 11,590,180 B2Granted
Bifidobacterium lactis GKK2, a composition comprising thereof and its use for improving allergic asthma
AssigneeGrape King Bio Ltd.
InventorsChin-Chu Chen, Yen-Lien Chen, Shin-Wei Lin, Yen-Po Chen, Ci-Sian Wang, Yu-Hsin Hou, Yang-Tzu Shih, Ching-Wen Lin, Ya-Jyun Chen, Jia-Lin Jiang
Life of this patent
Estimating the term…
Abstract
The present invention provides a Bifidobacterium lactis GKK2, a composition comprising thereof and its use for improving asthma, especially for lowering airway resistance, reducing levels of non-specific and specific IgE in serum, alleviating bronchoconstriction and increasing levels of GSH reductase in liver tissue interstitial fluid to improve allergic asthma.
Claims14
A method of improving airway constriction caused by airborne allergic asthma introduced by respiratory tract comprising:
- administering a composition comprising a Bifidobacterium lactis of an effective amount of 20-100 mg/60 kg body weight to a subject in need thereof,
- wherein the Bifidobacterium lactis is GKK2, deposited as CGMCC No. 15205 at China General Microbiological Culture Collection Center.
Dependencies are inferred from the claim text.